for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Oxford Biomedica Signs Clinical & Commercial Supply Agreement With Astrazeneca UK

May 28 (Reuters) - Oxford BioMedica PLC:

* OXFORD BIOMEDICA PLC - SIGNED A ONE YEAR CLINICAL & COMMERCIAL SUPPLY AGREEMENT WITH ASTRAZENECA UK LTD

* OXFORD BIOMEDICA PLC - AGREEMENT RELATES TO GMP MANUFACTURE OF ADENOVIRUS VECTOR BASED COVID-19 VACCINE CANDIDATE, AZD1222

* OXFORD BIOMEDICA- ASTRAZENECA WILL HAVE ACCESS TO CO’S NEW COMMERCIAL MANUFACTURING CENTRE OXBOX, LOCATED IN OXFORD, UK

* OXFORD BIOMEDICA PLC - PRODUCTION WILL BE FROM ONE OF GROUP’S RECENTLY APPROVED GMP SUITES IN OXBOX

* OXFORD BIOMEDICA PLC - COMMERCIAL SUPPLY AGREEMENT MAY BE EXTENDED FURTHER DEPENDING ON PROGRESSION OF PROGRAMME

* OXFORD BIOMEDICA -INITIAL DEAL REQUIRES CO TO GIVE ASTRAZENECA WITH MULTIPLE BATCHES OF VACCINE, MAJORITY EXPECTED TO BE PRODUCED THROUGHOUT 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up